Mirion Technologies Inc (NYSE:MIR) Reports Earnings and Beats Estimates by $0.01 per EPS

Mirion Technologies (NYSE:MIR – Get Rating) released its quarterly results on Wednesday. The company reported EPS of $0.10 for the quarter, beating consensus analyst estimates of $0.09 by $0.01, MarketWatch Earnings reports. Mirion Technologies posted a negative return on equity of 26.26% and a negative net margin of 37.22%.

NYSE MIR traded down $0.19 during Friday’s trading, hitting $7.14. 1,514,092 shares of the company were traded, against an average volume of 1,078,715. Mirion Technologies has a fifty-two week low of $6.78 and a fifty-two week high of $11.95. The company has a current ratio of 2.05, a quick ratio of 1.49 and a debt ratio of 0.45. The company’s fifty-day simple moving average is $8.04 and its 200-day simple moving average is $9.29.

Several research analysts have weighed in on the company recently. CJS Securities took over coverage from Mirion Technologies in a Thursday, March 24 research note. They set an “outperform” rating and a target price of $13.00 for the company. Goldman Sachs Group lowered its price target on Mirion Technologies from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Thursday.

A number of hedge funds and other institutional investors have recently changed their positions in MIR. BlackRock Inc. purchased a new stake in shares of Mirion Technologies during Q4 for a value of approximately $14,307,000. Wells Fargo & Company MN purchased a new equity stake in Mirion Technologies during Q4 for approximately $62,000. Weiss Multi Strategy Advisers LLC purchased a new stake in shares of Mirion Technologies during Q4 for a value of approximately $2,723,000. NewEdge Advisors LLC purchased a new stake in shares of Mirion Technologies during Q4 for a value of approximately $235,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of Mirion Technologies during the 4th quarter for a value of approximately $11,685,000. Hedge funds and other institutional investors own 78.79% of the company’s shares.

About Mirion Technologies (Get a rating)

Mirion Technologies, Inc provides radiation detection, measurement, analysis and monitoring products and services in the United States, Canada, United Kingdom, France, Germany, Finland, China, Belgium , the Netherlands, Estonia and Japan. It operates through two segments, medical and industrial. The medical segment offers quality assurance and dosimetry solutions in radiation oncology; patient safety solutions for diagnostic imaging and radiation therapy centers; radiotherapy quality assurance solutions for calibration and accuracy verification of imaging and treatment; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture and rehabilitation products.

Further reading

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in Mirion Technologies right now?

Before you consider Mirion Technologies, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Mirion Technologies was not on the list.

While Mirion Technologies currently enjoys a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Comments are closed.